|
INDOCO : INDOCO division is the largest division contributing to over 35%
of the total domestic sales.
The division focuses on major therapies like Anti-Infective, Gastro-intestinal,
Respiratory, Anti-Diabetics, Vitamins / Nutrients / Minerals and Dermatology
with well established brands in each of these segments.
Focused on General Practitioners, Gynecologists, Pediatricians Consulting
Physicians, ENT specialists & Dentist, INDOCO division has a strong equity
across all these specialities with a strong prescription base.
CYCLOPAM is the leading brand with revenue in excess of Rs. 500 million and
is the Number 1 brand in its segment.
Other major brands like Cloben-G, Oxipod, Tuspel-Plus, Clamchek, Karvol Plus,
Hemsyl, Nosic, Glychek, Losamax are amongst the top 5 brands in their respective
segments . New brands which have started showing their strong presence are Cyclochek,
Apispur & Oxipod-CV.
The Gynaecological & Paediatric portfolio which the division promotes will
be supported by brands like Cyclopam-MF, MCBM-DHA & Cyclopam-DF and Oxipod
with WFR and Oxipod-CV with WFR. (click
here to view product list)
|
| |
|
|
|
SPADE : Spade division contributes over 20% to the Domestic sales of Indoco
and has consistently registered a double digit growth. Febrex Plus, the largest
brand of the organization is marketed by Spade, which has steered the division’s
growth this year. Other therapies in which the division has a significant presence
are Anti-infectives, Calcium supplement and Hematinics. In addition to getting
major prescriptions from General Physicians, Pediatricians and Gynecologists,
Spade is making inroads into the prescription share of other Consultants like
Consultant Physicians, Chest Physicians, ENT Specialists and
Dermatologists. (click
here to view product list)
|
| |
|
|
|
SPERA : Spera division which was launched in year 2007 has registered a
decent performance. It is also expanding its reach in North zone to explore
potential of our legacy brands & capitalize opportunity for other products.
(click
here to view product list)
|
| |
|
|
|
WARREN : Warren division has become the second largest division of Indoco.
It is continuously showing healthy growth in stomatological market & is at number
1 position in this market over the past few years.(click
here to view product list)
|
| |
|
|
|
XTEND : This division was launched in April 2010 to cater the extra urban market
in selected states, traditionally strong for Indoco. Xtend division is marching ahead
with more than three brands crossing the Rs.10 million mark. The division caters to
therapies like Anti-Infectives, Analgesics, Antipyretics, Cough Syrups and Anti-Ulcerants
which are routinely prescribed in extra urban markets.
The largest brands viz. V-CEF-O, Pepchek, Bactogard, Osteoflam have started to gain
prescription momentum and all set to become mega brands for XTEND division.
With brands viz. Tuspel, Dolochek, Duochek and Proferrin, the division’s focus is to
penetrate the GP/Paediatrician segment.
Osteoflam-AQ Injections with its novel Painless high concentration, low volume
Diclofenac injectable form will be major new brands for the division. V-CEF- PLUS
a new brand of Cefixime and Ofloxacin combination will spread its tentacles faster
in the focused market. These brands will help the division to grow exponentially.
(click
here to view product list)
|
| |
|
|
|
EXCEL : The division majorly focuses on Ophthalmologists for prescriptions for
their ophthalmic preparations. Certain newer products in the high growth therapy
areas are contributing to the division’s growth. The Division also has a presence
in the Otologicals market through prescriptions from ENT Specialists and General
Physicians. The Division is venturing into new therapy areas for offering a
comprehensive Product basket to its key Specialty, Ophthalmologists. Homide
and Renolen, two of its legacy brands continue to do well in the respective
markets. (click
here to view product list)
|
| |
|
|
|
ETERNA : Eterna has made its presence felt in the Lifestyle disorders
segment along with making inroads in the Pain management segment. The Division
was operational in major parts of India through coverage of Orthopedicians,
Consulting Physicians and Gastroenterologists and is now looking at entering
three new states with a wider product basket and coverage of few more
specialties like Chest Physicians, Urologists and Nephrologists.
(click
here to view product list)
|
| |
|
|
|
INDOCO CND : New Division of Indoco, specially carved to strengthen
Indoco’s presence in super specialty market. The division will focus to
promote high growth chronic therapy products in Cardiac and Diabetic
markets particularly through super specialty doctors like Cardiologists,
Endocrinologists, Diabetologists, Nephrologists & Consulting Physicians.
Indoco CND has highly skilled field force of 245 people with Pan India presence,
promoting a wide range of products like Prichek, Amchek, Calaid, Telmichek,
Febubest, G-Neuro etc. (click
here to view product list)
|
| |
|
|
